Dr Martin MacDonald

Experts / Dr Martin MacDonald

Dr Martin MacDonald

Respiratory Physician, Monash Medical Centre; Head of Unit, Respiratory and General Medicine, Jessie McPherson Private Hospital

Martin completed undergraduate and basic physician training in the UK before emigrating to Melbourne in 2006. He completed Respiratory and Sleep Medicine training through Monash Medical Centre and St Vincent’s Hospital, Melbourne.

His PhD, awarded through Monash University, investigated clinical phenotyping of COPD exacerbations, with a focus on the interaction of cardiac disease and COPD.

He holds an academic appointment with Monash University and is a PhD supervisor. Martin has published extensively in leading journals including Lancet Respiratory Medicine, American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal, Chest and Respirology. He is a Deputy Editor for Respirology. His PhD was awarded the Fairfax Family research scholarship and he was a finalist for the prestigious Thoracic Society Australia and New Zealand New Investigator Award.

He works predominantly as a Respiratory and Sleep Physician at Monash Medical Centre and as Head of Unit for both Respiratory and General Medicine at Jessie McPherson Private Hospital. Through Monash Lung and Sleep Department he maintains an active research interest in COPD and severe asthma including biological therapies. He has expertise in a broad range of respiratory and sleep disorders and performs a weekly bronchoscopy list.

Fluticasone furoate/umeclidinium/vilanterol single inhaler triple therapy for the management of moderate to severe COPD

In this Product Explainer, Respiratory Physician Dr Martin MacDonald explains the role of single inhaler triple therapy containing fluticasone furoate/umeclidinium/vilanterol for the management of moderate to severe COPD (5 mins).

Fluticasone furoate/umeclidinium/vilanterol single inhaler triple therapy for the management of moderate to severe COPD

In this Product Explainer, Respiratory Physician Dr Martin MacDonald explains the role of single inhaler triple therapy containing fluticasone furoate/umeclidinium/vilanterol for the management of moderate to severe COPD (5 mins).

By Dr Martin MacDonald